| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8517371 | Neuropharmacology | 2018 | 25 Pages |
Abstract
Fingolimod mediates modulation of the RAGE axis which apparently contributes to the Fingolimod's anti-inflammatory and neuroprotective effects. These findings may provide a rationale for the clinical efficacy of Fingolimod in pathological states other than MS, where dysregulation of the RAGE axis plays a role.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Zohara Sternberg, Channa Kolb, Kailash Chadha, Adam Nir, Raphael Nir, Rayan George, Joseph Johnson, Jinhee Yu, David Hojnacki,